Movement Alert｜Hims & Hers Health Inc. Falls 5.01% in Regular Trading, Visa Monitoring Program and FTC Lawsuit Continue to Pressure Rebound

Market Focus08-28 21:58

On August 28, Hims & Hers Health Inc. fell 5.01% in regular trading, trading at $30.075/share, with turnover of $48.26 million. Despite Needham raising its target price to $42, which briefly lifted shares over 5%, the rally was quickly reversed as multiple headwinds persisted.

The company remains enrolled in Visa's Acquirer Monitoring Program following a surge in credit card disputes in its weight-loss subscription business in July. Each dispute carries an $8 surcharge resulting in a bill of nearly $75,000 in September. Hims must bring its dispute rate below 1.5% of transactions for three consecutive months to exit the program. Adding to the pressure, the FTC lawsuit alleging the company shared user health data with Meta and Snap without consent continues to weigh on sentiment. Meanwhile, Barclays lowered its price target from $39 to $35, maintaining an overweight rating, further constraining upside potential amid ongoing compliance and valuation concerns.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1183587878?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-28 21:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1183587878","market":"us","top_or_hot":-1,"title":"Movement Alert｜Hims & Hers Health Inc. Falls 5.01% in Regular Trading, Visa Monitoring Program and FTC Lawsuit Continue to Pressure Rebound","media":"Market Focus","content":"<p><p>On August 28, Hims & Hers Health Inc. fell 5.01% in regular trading, trading at $30.075/share, with turnover of $48.26 million. Despite Needham raising its target price to $42, which briefly lifted shares over 5%, the rally was quickly reversed as multiple headwinds persisted.</p><p>The company remains enrolled in Visa's Acquirer Monitoring Program following a surge in credit card disputes in its weight-loss subscription business in July. Each dispute carries an $8 surcharge resulting in a bill of nearly $75,000 in September. Hims must bring its dispute rate below 1.5% of transactions for three consecutive months to exit the program. Adding to the pressure, the FTC lawsuit alleging the company shared user health data with Meta and Snap without consent continues to weigh on sentiment. Meanwhile, Barclays lowered its price target from $39 to $35, maintaining an overweight rating, further constraining upside potential amid ongoing compliance and valuation concerns.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Hims & Hers Health Inc. Falls 5.01% in Regular Trading, Visa Monitoring Program and FTC Lawsuit Continue to Pressure Rebound</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Hims & Hers Health Inc. Falls 5.01% in Regular Trading, Visa Monitoring Program and FTC Lawsuit Continue to Pressure Rebound\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-08-28 21:58</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On August 28, Hims & Hers Health Inc. fell 5.01% in regular trading, trading at $30.075/share, with turnover of $48.26 million. Despite Needham raising its target price to $42, which briefly lifted shares over 5%, the rally was quickly reversed as multiple headwinds persisted.</p><p>The company remains enrolled in Visa's Acquirer Monitoring Program following a surge in credit card disputes in its weight-loss subscription business in July. Each dispute carries an $8 surcharge resulting in a bill of nearly $75,000 in September. Hims must bring its dispute rate below 1.5% of transactions for three consecutive months to exit the program. Adding to the pressure, the FTC lawsuit alleging the company shared user health data with Meta and Snap without consent continues to weigh on sentiment. Meanwhile, Barclays lowered its price target from $39 to $35, maintaining an overweight rating, further constraining upside potential amid ongoing compliance and valuation concerns.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HIMS","symbol_name":"Hims & Hers Health Inc.","start_time":0,"source_url":"","article_id":"1183587878","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1183587878","pubTimestamp":1787925487,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On August 28, Hims & Hers Health Inc. fell 5.01% in regular trading, trading at $30.075/share, with turnover of $48.26 million. Despite Needham raising its target price to $42, which briefly lifted...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"HIMS":"Hims & Hers Health Inc."},"translate_title":"走势警报|Hims & Hers Health Inc. 常规交易下跌 5.01%，签证监控计划和 FTC 诉讼继续施压反弹","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HIMS":1},"content_text":"On August 28, Hims & Hers Health Inc. fell 5.01% in regular trading, trading at $30.075/share, with turnover of $48.26 million. Despite Needham raising its target price to $42, which briefly lifted shares over 5%, the rally was quickly reversed as multiple headwinds persisted.The company remains enrolled in Visa's Acquirer Monitoring Program following a surge in credit card disputes in its weight-loss subscription business in July. Each dispute carries an $8 surcharge resulting in a bill of nearly $75,000 in September. Hims must bring its dispute rate below 1.5% of transactions for three consecutive months to exit the program. Adding to the pressure, the FTC lawsuit alleging the company shared user health data with Meta and Snap without consent continues to weigh on sentiment. Meanwhile, Barclays lowered its price target from $39 to $35, maintaining an overweight rating, further constraining upside potential amid ongoing compliance and valuation concerns.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.48.0","shortVersion":"4.48.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1183587878","isCrawlerRequest":true}